Skip to main content

Table 2 Characteristics of patients

From: Direct comparison of brain [18F]FDG images acquired by SiPM-based and PMT-based PET/CT: phantom and clinical studies

Pt. Clinical diagnosis Age Sex Weight (kg) Glucose (mg/dL) Injected dose (MBq) Uptake duration (min, PMT/SiPM)
1 MCI 72 Male 63.3 96 162.5 40.0/55.6
2 Amnesia 49 Male 73.1 102 151.7 40.0/54.5
3 FTLD 60 Female 63.0 95 149.3 40.0/57.5
4 Juvenile AD 49 Male 89.4 93 168.7 40.0/57.2
5 Juvenile AD 55 Male 65.4 111 172.1 40.0/56.8
6 MCI 70 Female 46.6 90 174.8 40.1/56.6
7 Amnesia, AD 81 Male 55.5 96 165.0 40.0/55.6
8 Dystonia 36 Female 42.9 99 172.2 40.0/54.7
9 Familial AD 55 Female 54.0 96 160.4 40.0/54.5
10 Posterior cortical atrophy 63 Male 61.3 100 140.1 40.0/57.0
Means ± SD - 59.0 ±13.1 - 61.5 ± 13.3 97.8 ± 5.8 161.7 ±11.4 40.0 ± 0.0/ 56.0 ± 1.2
  1. AD Alzheimer’s disease, FTLD Frontotemporal lobar degeneration, MCI Mild cognitive impairment, PMT Photomultiplier tube, SiPM Silicon photomultiplier